Cabozantinib
Who holds supplier records for Cabozantinib? 4 organisations hold a current record for Cabozantinib: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Cabozantinib: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/cabozantinib
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cabozantinib. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 43295 · latest filing Dec 2025
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 38207 · latest filing Mar 2023
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 40513, 41636 · latest filing Mar 2025
- SICHUAN ELIXIR PHARMACEUTICAL CO LTDActive DMF 39757 · latest filing Mar 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Cabozantinib is a small molecule kinase inhibitor that targets multiple tyrosine kinases, including VEGFR2 and MET. It is primarily utilized in the treatment of medullary thyroid cancer and renal cell carcinoma.
Chemical identity
- IUPAC name
- 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- Canonical SMILES
- COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
- InChIKey
- ONIQOQHATWINJY-UHFFFAOYSA-N
- Synonyms
- Cabometyx API, bms-907351 free base, xl-184 free base
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cabozantinib?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Cabozantinib: CHANGZHOU PHARMACEUTICAL FACTORY (China), Dr. Reddy's Laboratories Ltd. (India), MSN Laboratories Private Limited (India) and SICHUAN ELIXIR PHARMACEUTICAL CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cabozantinib Drug Master Files are active?
CHANGZHOU PHARMACEUTICAL FACTORY (DMF 43295), Dr. Reddy's Laboratories Ltd. (DMF 38207), MSN Laboratories Private Limited (DMF 40513, 41636) and SICHUAN ELIXIR PHARMACEUTICAL CO LTD (DMF 39757). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Cabozantinib supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cabozantinib?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.